Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-Dose Tamoxifen to Reduce High Background Parenchymal Uptake on Molecular Breast Imaging

NCT02979301 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02979301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02979301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-Dose Tamoxifen to Reduce High Background Parenchymal Uptake on Molecular Breast Imaging
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2017
Completion date
November 1, 2018
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high background uptake on mbi